Human Resources
MSD revealed as finalist in Australian HR Awards

The Australian HR Awards celebrates the outstanding achievements of the country’s top Human Resources leaders, companies and teams.
MSD reveals its success in securing a finalist position for the 2020 Australian HR Awards in the following categories:
- Best Workplace Flexibility Program
- Employer of Choice
- Australian HR Champion (CEO) of the Year
Australian HR Champion (CEO) of the Year
This year marks the first time MSD has submitted a nomination for Australian HR Champion (CEO) of the Year. MSD’s Managing Director Michael Azrak has been chosen as a finalist in this category, which recognises a CEO who has demonstrated excellence by driving successful HR strategies from the top and putting people at the centre of the organisation. Michael’s nomination in this award category recognises his people-focused leadership across MSD Australia, as well as his commitment to gender equality and diversity and inclusion. In addition, Michael drives his commitment to equity and diversity externally in his role as Pay Equity Ambassador for the Australian Workplace Gender Equality Agency (WGEA).
Employer of Choice
In 2019, MSD was awarded Employer of Choice for the second consecutive year. MSD is pleased to once again be a finalist in this category in 2020. MSD’s engagement score of 86% remains above the high-performing norm across the industry.
Best Workplace Flexibility Program
Flexibility is a core part of MSD’s culture at MSD. The company is proud to be finalists for Best Workplace Flexibility Program, as recognition of the work MSD does to normalise flexible working and enable this important practice for all colleagues. MSD was highly commended for this category in 2019, and was the winner in this category in 2018.
The Australian HR Awards will be announced on Thursday 3 December 2020.
Digital & Innovation
Health sector faces new privacy obligations
Healthcare organisations must update their privacy policies by 10 December if they use artificial intelligence (AI) or a computer program […]
MoreNews - Pharmaceuticals
TGA approves new antibiotic but AMR blind spot remains a critical concern
The Therapeutic Goods Administration (TGA) has approved a new antibiotic for the treatment of carbapenem-resistant Gram-negative bacterial infections. Developed by […]
MoreNews - MedTech & Diagnostics
BCAL Diagnostics rejects merger speculation
ASX-listed BCAL Diagnostics has moved to quash speculation of a potential three-way merger involving Genetic Signatures and Microba Life Sciences, […]
MoreNews - Pharmaceuticals
Australia backs infectious disease innovation as US funding faces more cuts
Biointelect Venturer, a national incubator supporting infectious disease innovation, will open its second funding round later this month, with AUD […]
More